Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients (OptiPEP)
Primary Purpose
Chronic Respiratory Failure
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Eole 3 ventilator - Resmed
Sponsored by
About this trial
This is an interventional treatment trial for Chronic Respiratory Failure focused on measuring Tracheostomy, positive end expiratory pressure, speech, respiratory failure, ventilation, neuromuscular disorders
Eligibility Criteria
Inclusion Criteria:
- Adult patient
- Stable state upon inclusion
- Neuromuscular patients, tracheostomized and on long term ventilation with a cuffless tube
- Assist control volumetric ventilation mode
- Signed consent form
Exclusion Criteria:
- Pregnancy
- Patients unable to read
- Acute respiratory failure
- Contra-indication of PEEP use
- Lack of social security coverage
Sites / Locations
- Hopital Raymond Poincare
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
No PEEP level
effective PEEP level (PEEPeff)
intermediate PEEP level (PEEP50)
Arm Description
protocol conducted while no PEEP is applied
PEEP level allowing the entire expiratory volume to go through the upper airways during quiet breathing
50% of PEEPeff
Outcomes
Primary Outcome Measures
Efficiency of PEEP level on speech
Measurement of the duration of a text passage reading, the maximal phonation time throughout the repsiratory cycle.
Secondary Outcome Measures
Effect of PEEP level on voice quality
Subjective evaluation by the patients with a visual analogic scale. Objective evaluation by two speech therapists (blinded to speech condition)assessing intelligibility, perceptual quality and prosody
Respiratory Comfort evaluated with a visual analogic scale by patients
Respiratory tolerance
Evaluation of respiratory tolerance through measurements of oxygen saturation , heart rate and respiratory rate
Use of PEEP control switch
number of use of the PEEP control switch during the text passage reading
Full Information
NCT ID
NCT01479959
First Posted
November 17, 2011
Last Updated
November 22, 2011
Sponsor
University of Versailles
Collaborators
Adep Assistance
1. Study Identification
Unique Protocol Identification Number
NCT01479959
Brief Title
Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients
Acronym
OptiPEP
Official Title
Determination of Optimal PEEP Level Under Patient Control in Tracheostomized Ventilated Patients
Study Type
Interventional
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
June 2010 (undefined)
Primary Completion Date
July 2011 (Actual)
Study Completion Date
July 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Versailles
Collaborators
Adep Assistance
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Adequate communication is a major part of the quality of life of tracheostomized ventilator dependent patients. Maintaining speech is therefore major goal in the management of these patients.
The use of a positive end-expiratory pressure (PEEP) during ventilation has allowed the improvement of speech. The best level for speech may vary from one patient to the other The purpose of this study is to determine individually the most efficient PEEP level in terms of speech while obtaining the most secure condition and the best possible respiratory tolerance. In order to improve the latter, the investigators will use a device which allows the patients to control the activation of PEEP so that they can use it only when needed (i.e. when they wish to speak). The investigators will compare the effect of different PEEP level to try to determine the best compromise to improve speech in tracheostomized ventilator-dependent patients.
Detailed Description
Context :
Allowing a functional communication is a major issue in order to preserve quality of life in tracheostomized ventilator-dependent patients.
We showed in a previous study that the use of a positive end-expiratory pressure (PEEP) in neuromuscular tracheostomized ventilator-dependent patients improved speech as it allows the patient to expire (at least partly) through the upper airways therefore to speak during expiration. The use of PEEP has been compared to the use of a phonation valve placed on the ventilator circuit which allows a complete expiration through the upper airways and therefore speech. Both techniques seem similar in terms of efficiency on speech; PEEP, however, is better tolerated and seems to be more secure (the system remains open during expiration decreasing the risk of high pressure, it does not require any handling of the ventilator circuit).
Optimal PEEP level allowing the patient to expire the total expiratory volume through the upper airways PEEPeff may vary from one patient to the other. We seek to determine individual PEEPeff and to compare it to 50% of its value (PEEPef50). Indeed, while PEEPeff may constitute the best level for expiratory speech as it mimics the mechanisms of a phonation valve without some of its fallbacks, by preventing expiration through the expiratory circuit of the ventilator, it also may lengthen expiration, delaying inspiration which allows speech, and facilitate hyperinflation leading to respiratory discomfort as we have previously observed with some patients using a phonation valve. Optimal PEEP level would be the best compromise between best possible phonation and best possible respiratory comfort and therefore could be lower than PEEPeff.
In order to improve respiratory comfort with higher PEEP level, we developed a prototype ventilator in which PEEP is activated by a switch under the control of patients who may activate it only when needed (during speech period).
Objective :
The main objective of the study is to optimize PEEP use both by determining individually its most appropriate level and by evaluation its use overtime to allow the best possible speech with the best respiratory comfort and the most secure condition for tracheostomized ventilated patients. Different PEEP levels will be evaluated and PEEP activation will be controlled by the patients.
Methods:
Open randomized monocentric cross-over study (the patients are their own control).
Optimal PEEP level (PEEPeff), defined as PEEP-level allowing complete expiration through the upper airways, will be determined for each patient. Speech and respiratory parameters were studied without PEEP, with PEEPeff and an intermediate PEEP-level(PEEP50). Flow and airway pressure will be measure and upper airways resistance will be calculated. Microphone speech recordings were subjected to both quantitative measurements and qualitative assessments of speech.
For each PEEP level the following protocol will be conducted: 5 minutes of quiet breathing with PEEP, 10 minutes spontaneous conversation, then speech trial(maximal sustained sound, glissando, text reading).
Subjective evaluation of speech and respiratory comfort(by the patient) and objective evaluation of speech improvement according to PEEP level (reading duration, phonation duration, voice quality, assessments of speech including an intelligibility score, a perceptual score and an evaluation of prosody analyzed by two experimented speech therapists blinded to PEEP level). Evaluation of the PEEP control button use by the patient.
Inclusion criteria:
Neuromuscular adult patients, tracheotomized and on long-term ventilation with a cuffless tube, on assist-control volumetric ventilation, in stable state at the time of the study.
Number of patients, center:
Considering it is a pilot study, 14 subjects will be included for the study. The subjects will be recruited in the home ventilation unit of the intensive care department of the R. Poincare teaching hospital (Garches, France) during their usual follow-up for their chronic respiratory failure.
Duration of study: 12 months. Duration of participation for each patient will be 1h30.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Respiratory Failure
Keywords
Tracheostomy, positive end expiratory pressure, speech, respiratory failure, ventilation, neuromuscular disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
14 (Actual)
8. Arms, Groups, and Interventions
Arm Title
No PEEP level
Arm Type
Active Comparator
Arm Description
protocol conducted while no PEEP is applied
Arm Title
effective PEEP level (PEEPeff)
Arm Type
Active Comparator
Arm Description
PEEP level allowing the entire expiratory volume to go through the upper airways during quiet breathing
Arm Title
intermediate PEEP level (PEEP50)
Arm Type
Active Comparator
Arm Description
50% of PEEPeff
Intervention Type
Device
Intervention Name(s)
Eole 3 ventilator - Resmed
Other Intervention Name(s)
Goodnight 420E, Tyco Healthcare, Puritan Bennett
Intervention Description
positive end expiratory pressure is added to the ventilation mode and it is activated by a switch under patient's control
Primary Outcome Measure Information:
Title
Efficiency of PEEP level on speech
Description
Measurement of the duration of a text passage reading, the maximal phonation time throughout the repsiratory cycle.
Time Frame
20 minutes
Secondary Outcome Measure Information:
Title
Effect of PEEP level on voice quality
Description
Subjective evaluation by the patients with a visual analogic scale. Objective evaluation by two speech therapists (blinded to speech condition)assessing intelligibility, perceptual quality and prosody
Time Frame
20 minutes
Title
Respiratory Comfort evaluated with a visual analogic scale by patients
Time Frame
20 minutes
Title
Respiratory tolerance
Description
Evaluation of respiratory tolerance through measurements of oxygen saturation , heart rate and respiratory rate
Time Frame
20 minute
Title
Use of PEEP control switch
Description
number of use of the PEEP control switch during the text passage reading
Time Frame
20 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adult patient
Stable state upon inclusion
Neuromuscular patients, tracheostomized and on long term ventilation with a cuffless tube
Assist control volumetric ventilation mode
Signed consent form
Exclusion Criteria:
Pregnancy
Patients unable to read
Acute respiratory failure
Contra-indication of PEEP use
Lack of social security coverage
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Helene PRIGENT, MD
Organizational Affiliation
Hôpital Raymond Poincaré - APHP
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Frederic LOFASO, MD-PhD
Organizational Affiliation
University of Versailles
Official's Role
Study Director
Facility Information:
Facility Name
Hopital Raymond Poincare
City
Garches
ZIP/Postal Code
92380
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
12406841
Citation
Prigent H, Samuel C, Louis B, Abinun MF, Zerah-Lancner F, Lejaille M, Raphael JC, Lofaso F. Comparative effects of two ventilatory modes on speech in tracheostomized patients with neuromuscular disease. Am J Respir Crit Care Med. 2003 Jan 15;167(2):114-9. doi: 10.1164/rccm.200201-026OC. Epub 2002 Oct 4.
Results Reference
background
PubMed Identifier
20535605
Citation
Prigent H, Garguilo M, Pascal S, Pouplin S, Bouteille J, Lejaille M, Orlikowski D, Lofaso F. Speech effects of a speaking valve versus external PEEP in tracheostomized ventilator-dependent neuromuscular patients. Intensive Care Med. 2010 Oct;36(10):1681-1687. doi: 10.1007/s00134-010-1935-0. Epub 2010 Jun 10.
Results Reference
background
PubMed Identifier
17533130
Citation
Pellegrini N, Pelletier A, Orlikowski D, Lolierou C, Ruquet M, Raphael JC, Lofaso F. Hand versus mouth for call-bell activation by DMD and Becker patients. Neuromuscul Disord. 2007 Jul;17(7):532-6. doi: 10.1016/j.nmd.2007.03.016. Epub 2007 May 29.
Results Reference
background
PubMed Identifier
2407453
Citation
Bach JR, Alba AS. Tracheostomy ventilation. A study of efficacy with deflated cuffs and cuffless tubes. Chest. 1990 Mar;97(3):679-83. doi: 10.1378/chest.97.3.679.
Results Reference
background
PubMed Identifier
14555587
Citation
Hoit JD, Banzett RB, Lohmeier HL, Hixon TJ, Brown R. Clinical ventilator adjustments that improve speech. Chest. 2003 Oct;124(4):1512-21. doi: 10.1378/chest.124.4.1512.
Results Reference
background
PubMed Identifier
8170131
Citation
Hoit JD, Shea SA, Banzett RB. Speech production during mechanical ventilation in tracheostomized individuals. J Speech Hear Res. 1994 Feb;37(1):53-63. doi: 10.1044/jshr.3701.53.
Results Reference
background
PubMed Identifier
23715608
Citation
Garguilo M, Leroux K, Lejaille M, Pascal S, Orlikowski D, Lofaso F, Prigent H. Patient-controlled positive end-expiratory pressure with neuromuscular disease: effect on speech in patients with tracheostomy and mechanical ventilation support. Chest. 2013 May;143(5):1243-1251. doi: 10.1378/chest.12-0574.
Results Reference
derived
Learn more about this trial
Impact of Patient Controlled Positive End-expiratory Pressure on Speech in Tracheostomized Ventilated Patients
We'll reach out to this number within 24 hrs